{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:27:54Z","timestamp":1794112074155,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cpcardiol.2024.102878","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:48:25Z","timestamp":1728553705000},"page":"102878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"50","author":[{"given":"Ayesha","family":"Younas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehreem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samay","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqsa","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa Arshad Azam","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Sehar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulqadir J.","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2024.102878_bib0001","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/cvr\/cvab264","article-title":"Risk factors profile of young and older patients with MI","volume":"118","author":"Sagris","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0002","first-page":"24656","article-title":"Association IO-J of the AH, 2022 undefined. Cardiac myosin inhibitors as a novel treatment option for obstructive hypertrophic cardiomyopathy: addressing the core of the matter","volume":"11","author":"Masri","year":"2022","journal-title":"Am Heart AssocA Masri, I Olivotto. J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute MI: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0004","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.clinthera.2022.06.009","article-title":"Efficacy of colchicine in the treatment of patients with coronary artery disease: a mini-review","volume":"44","author":"Yong","year":"2022","journal-title":"Clin Ther"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0005","first-page":"61","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","article-title":"Colchicine resistance and intolerance in familial mediterranean fever: definition, causes, and alternative treatments","volume":"47","author":"Ozen","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0007","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0008","article-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","author":"Higgins","year":"2024","journal-title":"Cochrane"},{"issue":"71","key":"10.1016\/j.cpcardiol.2024.102878_bib0009","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute MI: cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0011","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN: int\u00e9r\u00eat d'un traitement par colchicine dans l'infarctus du myocarde avec r\u00e9ponse inflammatoire","volume":"110","author":"Akodad","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after MI (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute MI","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0013","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc23-1825","article-title":"Low-dose colchicine in patients with type 2 diabetes and recent mi in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"47","author":"Roubille","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0015","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after MI","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0016","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute MI","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0017","first-page":"51","article-title":"Effects of the low-dose colchicine regimen on left ventricular adverse remodeling and systolic function in acute MI Patients with anterior ST","volume":"5","author":"Caesario","year":"2024","journal-title":"HeartscienceUbAcId"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.26911\/theijmed.2018.03.03.06","article-title":"Medicine BM-IJ of, 2018 undefined. the effect of colchicine administration on HsCRP level and mean platelet volume in patients with miocard acute infark. TheijmedComT Wasyanto, A Yasa","author":"Wasyanto","year":"2018","journal-title":"B MurtiIndonesian J Med"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0019","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute MI: A pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10787-021-00865-0","article-title":"Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation MI: a randomised, double-blind, placebo-controlled clinical trial","volume":"29","author":"Gholoobi","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0022","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0023","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102878_bib0024","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"issue":"42","key":"10.1016\/j.cpcardiol.2024.102878_bib0025","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"issue":"10448","key":"10.1016\/j.cpcardiol.2024.102878_bib0026","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (convince): A randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"The Lancet"},{"issue":"15","key":"10.1016\/j.cpcardiol.2024.102878_bib0027","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102878_bib0028","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.acvd.2020.04.007","article-title":"Colchicine and myocardial infarction: a review","volume":"113","author":"Akodad","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102878_bib0029","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2019.0179","article-title":"Association of initial and serial C-reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome","volume":"4","author":"Mani","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0030","doi-asserted-by":"crossref","unstructured":"Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 377(12), pp. 1119\u20131131.","DOI":"10.1056\/NEJMoa1707914"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102878_bib0031","first-page":"305","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC: Cardiovasc Imag"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102878_bib0032","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","article-title":"Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials","volume":"22","author":"Andreis","year":"2021","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2024.102878_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.676771","article-title":"Efficacy and safety of colchicine in post\u2013acute MI patients: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Diaz-Arocutipa","year":"2021","journal-title":"Front Cardiovasc Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:50:35Z","timestamp":1732744235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624005139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0146280624005139"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102878","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102878"}}